XML 16 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Investments:    
Fixed maturities available-for-sale, at fair value (amortized cost of $61,728 and $61,884) (allowance for credit losses of $2 and $4) $ 54,077 $ 55,165
Mortgage loans on real estate (net of allowance for credit losses of $270 and $277) 18,298 17,877
Policy loans 3,827 3,667
Other equity investments [1] 2,683 3,162
Trading securities, at fair value 809 257
Other invested assets 7,450 5,952
Total investments 87,144 86,080
Cash and cash equivalents 1,624 2,833
Deferred policy acquisition costs 4,685 4,759
Amounts due from reinsurers (allowance for credit losses of $8 and $7) 20,026 20,636
Loans to affiliates 1,900 1,900
Current and deferred income taxes 3,230 2,755
Purchased market risk benefits 13,033 16,729
Other assets 5,070 5,326
Assets for market risk benefits 781 574
Separate Accounts assets 125,807 121,497
Total Assets 263,300 263,089
LIABILITIES    
Policyholders’ account balances 84,206 82,990
Liability for market risk benefits 11,791 14,570
Future policy benefits and other policyholders' liabilities 16,653 16,573
Broker-dealer related payables 289 796
Amounts due to reinsurers 185 216
Funds withheld payable 9,802 10,603
Loans from affiliates 400 0
Reinsurance deposit liabilities 14,193 14,965
Other liabilities 2,805 2,496
Separate Accounts liabilities 125,807 121,497
Total Liabilities 266,131 264,706
Redeemable noncontrolling interest [2] 38 24
Commitments and contingent liabilities [3]
Equity attributable to Equitable Financial:    
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding 2 2
Additional paid-in capital 6,827 6,895
Accumulated deficit (1,814) (1,600)
Accumulated other comprehensive income (loss) (7,884) (6,938)
Total Equity (2,869) (1,641)
Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 263,300 $ 263,089
[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.
[2] See Note 21 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.
[3] See Note 18 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.